Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 11 de 11
Filtrar
1.
BMJ Open ; 14(1): e075920, 2024 01 11.
Artigo em Inglês | MEDLINE | ID: mdl-38216178

RESUMO

BACKGROUND: Employee Occupational Health ('occupational health') clinicians have expansive perspectives of the experience of healthcare personnel. Integrating mental health into the purview of occupational health is a newer approach that could combat historical limitations of healthcare personnel mental health programmes, which have been isolated and underused. OBJECTIVE: We aimed to document innovation and opportunities for supporting healthcare personnel mental health through occupational health clinicians. This work was part of a national qualitative needs assessment of employee occupational health clinicians during COVID-19 who were very much at the centre of organisational responses. DESIGN: This qualitative needs assessment included key informant interviews obtained using snowball sampling methods. PARTICIPANTS: We interviewed 43 US Veterans Health Administration occupational health clinicians from 29 facilities. APPROACH: This analysis focused on personnel mental health needs and opportunities, using consensus coding of interview transcripts and modified member checking. KEY RESULTS: Three major opportunities to support mental health through occupational health involved: (1) expanded mental health needs of healthcare personnel, including opportunities to support work-related concerns (eg, traumatic deployments), home-based concerns and bereavement (eg, working with chaplains); (2) leveraging expanded roles and protocols to address healthcare personnel mental health concerns, including opportunities in expanding occupational health roles, cross-disciplinary partnerships (eg, with employee assistance programmes (EAP)) and process/protocol (eg, acute suicidal ideation pathways) and (3) need for supporting occupational health clinicians' own mental health, including opportunities to address overwork/burn-out with adequate staffing/resources. CONCLUSIONS: Occupational health can enact strategies to support personnel mental health: to structurally sustain attention, use social cognition tools (eg, suicidality protocols or expanded job descriptions); to leverage distributed attention, enhance interdisciplinary collaboration (eg, chaplains for bereavement support or EAP) and to equip systems with resources and allow for flexibility during crises, including increased staffing.


Assuntos
Saúde Mental , Saúde Ocupacional , Humanos , Pessoal de Saúde/psicologia , Pesquisa Qualitativa , Avaliação das Necessidades
2.
J Gen Intern Med ; 37(7): 1737-1747, 2022 05.
Artigo em Inglês | MEDLINE | ID: mdl-35260957

RESUMO

BACKGROUND: In August 2021, up to 30% of Americans were uncertain about taking the COVID-19 vaccine, including some healthcare personnel (HCP). OBJECTIVE: Our objective was to identify barriers and facilitators of the Veterans Health Administration (VHA) HCP vaccination program. DESIGN: We conducted key informant interviews with employee occupational health (EOH) providers, using snowball recruitment. PARTICIPANTS: Participants included 43 VHA EOH providers representing 29 of VHA's regionally diverse healthcare systems. APPROACH: Thematic analysis elucidated 5 key themes and specific strategies recommended by EOH. KEY RESULTS: Implementation themes reflected logistics of distribution (supply), addressing any vaccine concerns or hesitancy (demand), and learning health system strategies/approaches for shared learnings. Specifically, themes included the following: (1) use interdisciplinary task forces to leverage diverse skillsets for vaccine implementation; (2) invest in processes and align resources with priorities, including creating detailed processes, addressing time trade-offs for personnel involved in vaccine clinics by suspending everything non-essential, designating process/authority to shift personnel where needed, and proactively involving leaders to support resource allocation/alignment; (3) expect and accommodate vaccine buy-in occurring over time: prepare for some HCP's slow buy-in, align buy-in facilitation with identities and motivation, and encourage word-of-mouth and hyper-local testimonials; (4) overcome misinformation with trustworthy communication: tailor communication to individuals and address COVID vaccines "in every encounter," leverage proactive institutional messaging to reinforce information, and invite bi-directional conversations about any vaccine concerns. A final overarching theme focused on learning health system needs and structures: (5) use existing and newly developed communication channels to foster shared learning across teams and sites. CONCLUSIONS: Expecting deliberation allows systems to prepare for complex distribution logistics (supply) and make room for conversations that are trustworthy, bi-directional, and identity aligned (demand). Ideally, organizations provide time for conversations that address individual concerns, foster bi-directional shared decision-making, respect HCP beliefs and identities, and emphasize shared identities as healthcare providers.


Assuntos
COVID-19 , Vacinas , COVID-19/prevenção & controle , Vacinas contra COVID-19 , Atenção à Saúde , Pessoal de Saúde , Humanos , Estados Unidos , United States Department of Veterans Affairs , Vacinação
3.
BMJ Open ; 11(10): e049134, 2021 10 04.
Artigo em Inglês | MEDLINE | ID: mdl-34607860

RESUMO

OBJECTIVE: Early in the COVID-19 pandemic, US Veterans Health Administration (VHA) employee occupational health (EOH) providers were tasked with assuming a central role in coordinating employee COVID-19 screening and clearance for duty, representing entirely novel EOH responsibilities. In a rapid qualitative needs assessment, we aimed to identify learnings from the field to support the vastly expanding role of EOH providers in a national healthcare system. METHODS: We employed rapid qualitative analysis of key informant interviews in a maximal variation sample on the parameters of job type, rural versus urban and provider gender. We interviewed 21 VHA EOH providers between July and December 2020. This sample represents 15 facilities from diverse regions of the USA (large, medium and small facilities in the Mid-Atlantic; medium sites in the South; large facilities in the West and Pacific Northwest). RESULTS: Five interdependent needs included: (1) infrastructure to support employee population management, including tools that facilitate infection control measures such as contact tracing (eg, employee-facing electronic health records and coordinated databases); (2) mechanisms for information sharing across settings (eg, VHA listserv), especially for changing policy and protocols; (3) sufficiently resourced staffing using detailing to align EOH needs with human resource capital; (4) connected and resourced local and national leaders; and (5) strategies to support healthcare worker mental health.Our identified facilitators for EOH assuming new challenging and dynamically changing roles during COVID-19 included: (A) training or access to expertise; (B) existing mechanisms for information sharing; (C) flexible and responsive staffing; and (D) leveraging other institutional expertise not previously affiliated with EOH (eg, chaplains to support bereavement). CONCLUSIONS: Our needs assessment highlights local and system level barriers and facilitators of EOH assuming expanded roles during COVID-19. Integrating changes both within and across systems and with alignment of human capital will enable EOH preparedness for future challenges.


Assuntos
COVID-19 , Saúde Ocupacional , Pessoal de Saúde , Humanos , Avaliação das Necessidades , Pandemias , SARS-CoV-2 , Saúde dos Veteranos , Recursos Humanos
4.
J Occup Environ Med ; 62(7): e355-e369, 2020 07.
Artigo em Inglês | MEDLINE | ID: mdl-32730040

RESUMO

: On May 17, 2019, the US Centers for Disease Control and Prevention and National Tuberculosis Controllers Association issued new Recommendations for Tuberculosis Screening, Testing, and Treatment of Health Care Personnel, United States, 2019, updating the health care personnel-related sections of the Guidelines for Preventing the Transmission of Mycobacterium tuberculosis in Health-Care Settings, 2005. This companion document offers the collective effort and experience of occupational health, infectious disease, and public health experts from major academic and public health institutions across the United States and expands on each section of the 2019 recommendations to provide clarifications, explanations, and considerations that go beyond the 2019 recommendations to answer questions that may arise and to offer strategies for implementation.


Assuntos
Transmissão de Doença Infecciosa/prevenção & controle , Pessoal de Saúde/normas , Tuberculose/diagnóstico , Tuberculose/terapia , Comitês Consultivos/organização & administração , Comitês Consultivos/normas , Centers for Disease Control and Prevention, U.S./normas , Humanos , Controle de Infecções/normas , Tuberculose Latente/diagnóstico , Tuberculose Latente/prevenção & controle , Tuberculose Latente/terapia , Tuberculose Latente/transmissão , Programas de Rastreamento/normas , Mycobacterium tuberculosis/isolamento & purificação , Saúde Ocupacional/normas , Medição de Risco , Sociedades Médicas/normas , Tuberculose/prevenção & controle , Tuberculose/transmissão , Estados Unidos
5.
MMWR Morb Mortal Wkly Rep ; 68(19): 439-443, 2019 May 17.
Artigo em Inglês | MEDLINE | ID: mdl-31099768

RESUMO

The 2005 CDC guidelines for preventing Mycobacterium tuberculosis transmission in health care settings include recommendations for baseline tuberculosis (TB) screening of all U.S. health care personnel and annual testing for health care personnel working in medium-risk settings or settings with potential for ongoing transmission (1). Using evidence from a systematic review conducted by a National Tuberculosis Controllers Association (NTCA)-CDC work group, and following methods adapted from the Guide to Community Preventive Services (2,3), the 2005 CDC recommendations for testing U.S. health care personnel have been updated and now include 1) TB screening with an individual risk assessment and symptom evaluation at baseline (preplacement); 2) TB testing with an interferon-gamma release assay (IGRA) or a tuberculin skin test (TST) for persons without documented prior TB disease or latent TB infection (LTBI); 3) no routine serial TB testing at any interval after baseline in the absence of a known exposure or ongoing transmission; 4) encouragement of treatment for all health care personnel with untreated LTBI, unless treatment is contraindicated; 5) annual symptom screening for health care personnel with untreated LTBI; and 6) annual TB education of all health care personnel.


Assuntos
Pessoal de Saúde , Programas de Rastreamento , Mycobacterium tuberculosis , Tuberculose/prevenção & controle , Centers for Disease Control and Prevention, U.S. , Humanos , Testes de Liberação de Interferon-gama , Tuberculose Latente/epidemiologia , Tuberculose Latente/prevenção & controle , Medição de Risco , Revisões Sistemáticas como Assunto , Teste Tuberculínico , Tuberculose/epidemiologia , Tuberculose/transmissão , Estados Unidos/epidemiologia
7.
Infect Control Hosp Epidemiol ; 37(4): 478-82, 2016 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-26818401

RESUMO

QuantiFERON tuberculosis tests (QFT) reverted in (612) 77% of 1,094 low-risk healthcare workers (HCW) testing less than 1.16 IU/mL. Of HCW testing greater than 1.1 IU/mL, 33 (59%) of 56 with negative tuberculin skin tests (TST) reverted vs 8 (6%) of 125 with positive TSTs. Retesting low-risk QFT-positive and TST-negative HCW is prudent.


Assuntos
Pessoal de Saúde/estatística & dados numéricos , Testes de Liberação de Interferon-gama/normas , Programas de Rastreamento/métodos , Teste Tuberculínico , Tuberculose/diagnóstico , Adulto , Estudos de Coortes , Humanos , Pessoa de Meia-Idade , Curva ROC , Estados Unidos , Adulto Jovem
8.
Infect Control Hosp Epidemiol ; 34(6): 625-30, 2013 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-23651895

RESUMO

On June 13, 2012, a group of key stakeholders, leaders, and national experts on tuberculosis (TB), occupational health, and laboratory science met in Atlanta, Georgia, to focus national discussion on the higher than expected positive results occurring among low-risk, unexposed healthcare workers undergoing serial testing with interferon-γ release assays (IGRAs). The objectives of the meeting were to present the latest clinical and operational research findings on the topic, to discuss evaluation and treatment algorithms that are emerging in the absence of national guidance, and to develop a consensus on the action steps needed to assist programs and physicians in the interpretation of serial testing IGRA results. This report summarizes its proceedings.


Assuntos
Testes de Liberação de Interferon-gama/normas , Saúde Ocupacional , Guias de Prática Clínica como Assunto , Tuberculose/diagnóstico , Setor de Assistência à Saúde , Humanos , Curva ROC , Tuberculose/tratamento farmacológico , Tuberculose/prevenção & controle , Estados Unidos
9.
Pulm Med ; 2012: 291294, 2012.
Artigo em Inglês | MEDLINE | ID: mdl-23326660

RESUMO

Objective. To find a statistically significant separation point for the QuantiFERON Gold In-Tube (QFT) interferon gamma release assay that could define an optimal "retesting zone" for use in serially tested low-risk populations who have test "reversions" from initially positive to subsequently negative results. Method. Using receiver operating characteristic analysis (ROC) to analyze retrospective data collected from 3 major hospitals, we searched for predictors of reversion until statistically significant separation points were revealed. A confirmatory regression analysis was performed on an additional sample. Results. In 575 initially positive US healthcare workers (HCWs), 300 (52.2%) had reversions, while 275 (47.8%) had two sequential positive tests. The most statistically significant (Kappa = 0.48, chi-square = 131.0, P < 0.001) separation point identified by the ROC for predicting reversion was the tuberculosis antigen minus-nil (TBag-nil) value at 1.11 International Units per milliliter (IU/mL). The second separation point was found at TBag-nil at 0.72 IU/mL (Kappa = 0.16, chi-square = 8.2, P < 0.01). The model was validated by the regression analysis of 287 HCWs. Conclusion. Reversion likelihood increases as the TBag-nil approaches the manufacturer's cut-point of 0.35 IU/mL. The most statistically significant separation point between those who test repeatedly positive and those who revert is 1.11 IU/mL. Clinicians should retest low-risk individuals with initial QFT results < 1.11 IU/mL.

11.
J Emerg Med ; 37(1): 21-8, 2009 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-18657927

RESUMO

The presenting symptoms of meningococcemia are protean, and the illness is rapidly progressive and often fatal, making it simultaneously one of the most dangerous and most important illnesses the Emergency Physician can encounter. It attacks the young and it is highly contagious. This report uses one of the many unusual presentations of meningococcemia as a framework for discussing the epidemiology, presentation, diagnosis, and treatment of meningococcal disease.


Assuntos
Infecções Meningocócicas/diagnóstico , Dor Abdominal/etiologia , Adolescente , Diagnóstico Diferencial , Evolução Fatal , Feminino , Febre/etiologia , Humanos , Leucopenia/etiologia , Masculino
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...